Sublingual immunotherapy not effective in house dust mite-allergic children in primary care
Pediatric Allergy and Immunology, 10/24/2011
De Bot CMA et al. – Sublingual immunotherapy with house dust mite allergen was not better than placebo in reducing rhinitis symptoms in house dust mite–allergic children in primary care. SLIT as administered in this study can be considered safe.